- Approval Id
- 9b9d49221a5b191b
- Drug Name
- LACIPIL TABLET 4 MG
- Product Name
- LACIPIL TABLET 4 MG
- Approval Number
- SIN07934P
- Approval Date
- 1994-11-25
- Registrant
- GLAXOSMITHKLINE PTE LTD
- Licence Holder
- GLAXOSMITHKLINE PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>Dosage and Administration</strong></p>
<p>The initial dosage is 2 mg once daily. It should be taken at the same time each day, preferably in the morning, with or without food.</p>
<p>The treatment of hypertension should be adapted to the severity of the condition, and according to individual response.</p>
<p>The dose may be increased to 4 mg and if necessary to 6 mg, after adequate time has been allowed for the full pharmacological effect to occur. In practice this should not be less than three to four weeks, unless the clinical condition requires a more rapid upward titration.</p>
<p>Treatment may be continued indefinitely.</p>
<ul class="bullet">
<li><p><strong>Hepatic impairment</strong></p>
<p>No dose modification is required in patients with mild or moderate hepatic impairment. Insufficient data are available to make a recommendation for patients with severe hepatic impairment (see Warnings and Precautions – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>).</p></li>
<li><p><strong>Renal impairment</strong></p>
<p>As lacidipine is not excreted by the kidneys the dose does not require modification in patients with renal impairment.</p></li>
<li><p><strong>Children</strong></p>
<p>No experience has been gained with lacidipine in children.</p></li>
<li><p><strong>Elderly</strong></p>
<p>No dose modification is required.</p></li>
</ul>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications</strong></p>
<p>As a treatment of hypertension either alone or in combination with other antihypertensive agents, e.g. beta-blockers, diuretics and ACE inhibitors.</p>
- Contraindications
- <p><strong>Contraindications</strong></p>
<ul class="dash">
<li><p>Hypersensitivity to any component of the preparation.</p></li>
<li><p>As with other dihydropyridines, <em>LACIPIL</em> is contraindicated in patients with severe aortic stenosis.</p></li>
</ul>
- Atc Code
- C08CA09
- Atc Item Name
- lacidipine
- Pharma Manufacturer Name
- GLAXOSMITHKLINE PTE LTD
